Key result
Low-dose reserpine use was not associated with depression in older hypertensive patients, with mean depression scores of 40.4 in reserpine users and 40.6 in non-users.
Why the study?
Reserpine is widely used by Chinese hypertensive patients despite ongoing concerns regarding its depressogenic effect, even at low doses.
Does low-dose reserpine use increase the risk of depression in older hypertensive patients?
Cross-Sectional (n=1,574)
Yes
Does low-dose reserpine use increase the risk of depression in older hypertensive patients?
Answers are grounded in this paper and cite their sources.
No practice change from cross-sectional data alone; leaves open any causal link to depression.
BACKGROUND: Reserpine is currently used by millions of Chinese hypertensive patients, in spite of the continued concern of its depressogenic effect, even when used in low dose. This study aimed to investigate the association between low-dose reserpine use and depression in older Chinese hypertensive patient. METHODS: In this cross-sectional, case-control study, we recruited patient aged 60 years or over who had regularly taken one or two tables of "compound reserpine and triamterene tablets (CRTTs)" for more than one year (reserpine user) from 26 community health centers located in 10 provinces in China. For each patient who took CRTTs, we selected an age (within five years) and sex matched hypertensive patient who had never taken any drugs containing reserpine (non-reserpine user) as control. Depressive symptoms were evaluated using a Chinese depression scale adapted from the Zung Self-Rating Depression Scale. Demographic, clinical data and laboratory examination results within six months were collected. The majority of study subject had a depression score < 53 (87.6% in reserpine users and 88.2% in non-reserpine users, respectively). There were no significant differences in the prevalence of mild, moderate or severe depression in reserpine users and non-reserpine users. CONCLUSIONS: There is no association between low-dose reserpine use and depression in older hypertensive patient. The role of reserpine in the treatment and control of hypertension should be reconsidered; and further studies, especially randomized, controlled clinical trials to compare efficacy and safety of reserpine and other widely recommended anti-hypertensive agents are needed.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2019) conducted a cross-sectional in Hypertension (n=1,574). Low-dose reserpine vs. Non-reserpine user was evaluated on Mean depression score (Zung Self-Rating Depression Scale) (p=0.70). Low-dose reserpine use was not associated with depression in older hypertensive patients, with mean depression scores of 40.4 in reserpine users and 40.6 in non-users.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: